FDA/SEC Communication Will Be “Systematized” In Response To Erbitux
Executive Summary
FDA's Good Review Management Practices guidance will formalize communications with SEC regarding potentially misleading statements made by sponsors in the preapproval stage, Acting Commissioner Crawford told the House Energy & Commerce/Oversight Subcommittee Oct. 10
You may also be interested in...
FDA Consulting Policy Shifts As Investigation Of Employee Activities Gears Up
FDA has revised its procedures for the review of outside activities by agency employees to require that they be approved by center directors
FDA Consulting Policy Shifts As Investigation Of Employee Activities Gears Up
FDA has revised its procedures for the review of outside activities by agency employees to require that they be approved by center directors
FDA/SEC Cooperation On Investor Communications To Be Headed By Taylor
FDA Associate Commissioner for Regulatory Affairs John Taylor will serve as the liaison with the Securities & Exchange Commission as FDA expands its role in regulating investor communications